Herein, we demonstrated that inhibiting the upstream molecule MEK, ERK itself, and specifically ERK2 (MAPK1) all trigger the EMT program, leading to ACACA‐depleted prostate cancer cell migration. Here, MAP2K7 is linked to prostate cancer.